Worry about ovarian cancer risk and use of screening by high-risk women: How you recruit affects what you find

American Journal of Medical Genetics

Volumn 129, Issue 2, 2004, Pages 130-135

  Andersen, M Robyn ^a,c,e   Nelson, Judy ^a   Peacock, Sue ^a   Giedzinska, Antoinette ^d   Dresher, Charles ^b   Bowen, Deborah ^a,c   Urban, Nicole ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Marsha Rivkin Center for Ovarian Cancer Research   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NONE   (United States)

Author keywords

Cancer screening; Cancer worry; High risk; Recruitment

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PATIENT ATTITUDE; PATIENT REFERRAL; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLE SIZE;

EID: 4344650940     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30247     Document Type: Article

References (17)

1. American Cancer Society. 2002. American Cancer Society cancer facts and figures-2002. Atlanta, GA: American Cancer Society, Inc.
2. American Society of Clinical Oncology. 1996. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736.
3. Andersen MR, Bowen D, Yasui Y, McTiernan A. 2002a. Awareness and concern about ovarian cancer among women at risk due to a family history of breast or ovarian cancer. Clin J Women Health 2:5-12.
4. Andersen MR, Peacock S, Nelson J, Wilson S, McIntosh M, Dresher C, Urban N. 2002b. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol 85:3-8.
5. Crump C, McIntosh MW, Urban N, Anderson G, Karlan BY. 2000. Ovarian cancer tumor marker behavior in asympomatic healthy women: Implications for screening. Cancer Epidemiol Biomarkers Prev 9:1107-1111.
6. Drescher C, Holt SK, Andersen MR, Anderson G, Urban N. 2000. Reported ovarian cancer screening among a populations-based sample in Washington state. Obstet Gynecol 96:70-74.
7. Isaacs C, Peshkin BN, Schwartz M, Demarco TA, Main D, Lerman C. 2002. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71:103-112.
8. Karlan BY. 1997. The status of ultrasound and color Doppler imaging for the early detection of ovarian carcinoma. Cancer Invest 15:265-269.
9. Karlan BY, Raffel LJ, Crvenkovic G, Smrt C, Chen D, Lopes E, Walla CA, Garber C, Cane P, Sarti DA, Rotter JI, Platt LD. 1993. A multidisciplinary approach to the early detection of ovarian carcinoma: Rationale, protocol design, and early results. Am J Obstet Gynecol 169:494-501.
10. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. 1991. Psychological side effects of breast cancer screening. Health Psychol 10:259-267.
11. Muto MG, Cramer DW, Brown DL, Welch WR, Harlow BL, Xu H, Brucks JP, Tsao SW, Berkowitz RS. 1993. Screening for ovarian cancer: The preliminary experience of a familial ovarian cancer center. Gynecol Oncol 51:11-20.
12. Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM. 1991. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338:82-83.
13. NCI Breast Cancer Screening Consortium. 1990. Screening mammography: A missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Studies. J Am Med Assoc 264:54-58.
14. Robinson EG, Rosen BP, Bradley LN, Rockert WG, Carr ML, Cole DE, Murphy KJ. 1997. Psychological impact of screening for familial ovarian cancer: Reactions to initial assessment. Gynecol Oncol 65:197-205.
15. Schwartz M, Lerman C, Daly M, Audrain J, Masny A, Griffith K. 1995. Utilization of ovarian cancer screening by women at increased risk. Cancer Epidemiol Biomarkers Prev 4:269-273.
16. Stoddard AM, Rimer BK, Lane D, Fox SA, Lipkus I, Luckmann R, Avrunin JS, Sprachman S, Costanza M, Urban N. 1998. Underusers of mammogram screening: Stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium. Prev Med 27:478-487.
17. Trask PC, Paterson AG, Wang C, Hayaska S, Milliron KJ, Blumberg LR, Gonzalez R, Murray S, Merajver SD. 2001. Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: Impact on emotional distress and health functioning. Psycho-oncology 10:349-360.